Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Zinhle Essamuah joins NBC News Daily as newest co-anchor

    03:01

  • Now Playing

    Eli Lilly Alzheimer’s drug could slow disease, but comes with side effects

    03:15

  • UP NEXT

    Search continues for missing infant boy and sister amid Pennsylvania flash floods

    02:54

  • Sailor and dog rescued after missing in Pacific Ocean for 2 months

    02:02

  • Actors hit picket lines for first full week of strike

    02:52

  • 14-year-old hired to animate Lego scenes in ‘Spider-Man: Across the Spider-Verse’

    02:50

  • Elton John testifies for the defense in Kevin Spacey sexual assault trial

    02:37

  • Texas boy looking for friends goes viral on TikTok

    03:08

  • Trump, DeSantis and Suarez compete for Hispanic vote in Florida

    02:42

  • Gilgo Beach suspect identified as 59-year-old Rex Heuermann

    03:35

  • Secret Service ends investigation into cocaine found at White House

    01:55

  • Biden touts U.S. commitment to NATO during visit to Finland

    02:21

  • FDA approves first over-the-counter birth control pill

    02:45

  • Why Gen Z has such a problem with the period in texting

    04:47

  • Plane crash survivor and nurse reflect on unbreakable bond

    02:11

  • Orthopedic surgeon fatally shot by patient in Tennessee

    02:14

  • Orlando police release bodycam footage of deadly shooting

    02:41

  • Biden delivers speech at NATO summit after meeting with Zelenskyy

    02:41

  • Bank of America ordered to pay more than $100 million to customers after illegal activity

    02:08

  • Father of woman recalls moment she was swept away in New York flash flood

    01:58

An experimental Alzheimer’s drug from the drugmaker Eli Lilly may soon be another option to slow the progression of the disease. NBC News’ Berkeley Lovelace Jr. talks about the potential side effects and details how soon people could have access to the medication. 

Source

Leave a Reply